As of January 22, 2025, Innoviva (INVA) has a market cap of $1.16 billion USD. According to our data, Innoviva is ranked No.4980 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.16 B |
6.80%
|
Dec 31, 2024 | $1.09 B |
8.17%
|
Dec 29, 2023 | $1.00 B |
21.06%
|
Dec 30, 2022 | $0.83 B |
-23.19%
|
Dec 31, 2021 | $1.08 B |
39.23%
|
Dec 31, 2020 | $0.78 B |
-12.50%
|
Dec 31, 2019 | $0.89 B |
-18.85%
|
Dec 31, 2018 | $1.09 B |
22.97%
|
Dec 29, 2017 | $0.89 B |
32.62%
|
Dec 30, 2016 | $0.67 B |
1.52%
|
Dec 31, 2015 | $0.66 B |
-22.29%
|
Dec 31, 2014 | $0.85 B |
-49.29%
|
Dec 31, 2013 | $1.67 B |
60.30%
|
Dec 31, 2012 | $1.04 B |
0.63%
|
Dec 30, 2011 | $1.04 B |
-11.85%
|
Dec 31, 2010 | $1.18 B |
91.81%
|
Dec 31, 2009 | $0.61 B |
5.49%
|
Dec 31, 2008 | $0.58 B |
-36.46%
|
Dec 31, 2007 | $0.92 B |
-36.87%
|
Dec 29, 2006 | $1.45 B |
37.17%
|
Dec 30, 2005 | $1.06 B |
25.81%
|
Dec 31, 2004 | $0.84 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Theravance Biopharma
TBPH
|
$0.46 B |
-0.000 M
|
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Market Cap | = | INVA Stock Price | * | INVA Shares Outstanding |
= | $18.53 | * | 62.60 M | |
= | $1.16 B |